Ratings and price targets from Goldman Sachs analysts, and how many of their targets were reached. Latest call 13 November 2026.
1,088 Buy, 806 Hold and 278 Sell from 31 October 2025 to 30 October 2026. 882 target raises and 701 cuts.
Targets set above the share price from 2008 to October 2025. Across all firms the figure is 59.2%. How we measure.
Share of the 626 stocks with a sector on AnaChart.
| Analyst | Ratings, 12 mo | Price targets | Stocks | Avg upside | Targets met | Last call |
|---|---|---|---|---|---|---|
| James Yaro | Buy 46%Hold 44%Sell 10% | 215 | 25 | +15.5% | 13 Nov 2026 | |
| Will Nance | Buy 46%Hold 43%Sell 10% | 685 | 63 | +11.9% | 13 Nov 2026 | |
| John Mackay | Buy 50%Hold 33%Sell 17% | 262 | 44 | +21.6% | 13 Nov 2026 | |
| George Tong | Buy 38%Hold 41%Sell 21% | 756 | 82 | +20.3% | 13 Nov 2026 | |
| Julien Blouin | Buy 50%Hold 25%Sell 25% | 52 | 17 | +19.2% | 12 Nov 2026 | |
| Kate McShane | Buy 54%Hold 25%Sell 22% | 1,325 | 100 | +50.7% | 12 Nov 2026 | |
| Tito Labarta | Buy 50%Hold 45%Sell 5% | 270 | 32 | +26% | 12 Nov 2026 | |
| Bonnie Herzog | Buy 43%Hold 39%Sell 17% | 562 | 45 | +14.2% | 12 Nov 2026 | |
| James Schneider | Buy 50%Hold 35%Sell 16% | 435 | 105 | +15% | 12 Nov 2026 | |
| Alexander Blostein | Buy 49%Hold 39%Sell 13% | 984 | 82 | +21.3% | 10 Nov 2026 | |
| George Kelly | Buy 0%Hold 0%Sell 100% | 239 | 42 | +28% | 10 Nov 2026 | |
| Salveen Richter | Buy 36%Hold 59%Sell 5% | 671 | 90 | +38% | 10 Nov 2026 | |
| Eric Sheridan | Buy 51%Hold 42%Sell 7% | 1,838 | 122 | +24.1% | 9 Nov 2026 | |
| Patrick Creuset | Buy 50%Hold 50%Sell 0% | 38 | 10 | +22.8% | 6 Nov 2026 | |
| Brian Lee | Buy 46%Hold 44%Sell 10% | 934 | 82 | +21% | 6 Nov 2026 | |
| Gabriela Borges | Buy 62%Hold 24%Sell 14% | 535 | 75 | +29.5% | 5 Nov 2026 | |
| Michael Ng | Buy 44%Hold 47%Sell 8% | 668 | 105 | +14.4% | 5 Nov 2026 | |
| Joe Ritchie | Buy 60%Hold 38%Sell 2% | 629 | 70 | +10.5% | 5 Nov 2026 | |
| Kash Rangan | Buy 56%Hold 35%Sell 9% | 1,139 | 92 | +15.4% | 5 Nov 2026 | |
| Mark Delaney | Buy 47%Hold 41%Sell 11% | 924 | 73 | +13.6% | 4 Nov 2026 | |
| Lizzie Dove | Buy 49%Hold 35%Sell 15% | 260 | 42 | +5.3% | 3 Nov 2026 | |
| Stephen Laszczyk | Buy 45%Hold 36%Sell 18% | 133 | 21 | +7.6% | 3 Nov 2026 | |
| Caitlin Burrows | Buy 47%Hold 26%Sell 26% | 377 | 44 | +16.7% | 2 Nov 2026 | |
| Brooke Roach | Buy 36%Hold 49%Sell 15% | 592 | 64 | +1.7% | 2 Nov 2026 | |
| Adam Bubes | Buy 46%Hold 33%Sell 21% | 49 | 15 | +10.7% | 2 Nov 2026 | |
| Jordan Alliger | Buy 68%Hold 26%Sell 5% | 386 | 39 | +10.6% | 2 Nov 2026 | |
| Richard Law | Buy 58%Hold 31%Sell 12% | 119 | 25 | +37.9% | 30 Oct 2026 | |
| Paul Choi | Buy 50%Hold 43%Sell 7% | 266 | 58 | +48.6% | 28 Oct 2026 | |
| Neil Mehta | Buy 60%Hold 31%Sell 9% | 929 | 90 | +14.7% | 27 Oct 2026 | |
| Bruno Amorim | Buy 40%Hold 60%Sell 0% | 185 | 28 | +8.6% | 19 Oct 2026 | |
| Adam Samuelson | Buy 100%Hold 0%Sell 0% | 163 | 26 | +16% | 16 Oct 2026 | |
| Ronald Keung | Buy 67%Hold 33%Sell 0% | 110 | 19 | +24.1% | 15 Oct 2026 | |
| Ati Modak | Buy 50%Hold 35%Sell 15% | 141 | 28 | +15.6% | 14 Oct 2026 | |
| Noah Poponak | Buy 55%Hold 27%Sell 18% | 509 | 72 | +27.7% | 12 Oct 2026 | |
| Susan Maklari | Buy 46%Hold 37%Sell 17% | 718 | 62 | +13.8% | 12 Oct 2026 | |
| Duffy Fischer | Buy 38%Hold 44%Sell 18% | 352 | 46 | +16.3% | 12 Oct 2026 | |
| Richard Ramsden | Buy 57%Hold 26%Sell 17% | 307 | 25 | +14.2% | 5 Oct 2026 | |
| Catherine O'Brien | Buy 54%Hold 4%Sell 42% | 290 | 26 | +8.1% | 2 Oct 2026 | |
| Andrea Tan | Buy 52%Hold 35%Sell 13% | 150 | 37 | +45.1% | 24 Sep 2026 | |
| Evie Koslosky | Buy 57%Hold 36%Sell 7% | 4 | 2 | n/a | Under 5 targets | 21 Sep 2026 |
| Alexandra Steiger | Buy 50%Hold 50%Sell 0% | 126 | 17 | +26.6% | 11 Sep 2026 | |
| Gavin Parsons | Buy 0%Hold 33%Sell 67% | 47 | 3 | +15% | 8 Sep 2026 | |
| Mike Burton | n/a | 101 | 20 | +15.5% | 4 Sep 2026 | |
| Umang Choudhary | Buy 38%Hold 25%Sell 38% | 77 | 18 | +12.3% | 2 Sep 2026 | |
| Katherine Murphy | Buy 50%Hold 13%Sell 38% | 9 | 2 | +3.1% | 2 Sep 2026 | |
| Matthew O'Neill | n/a | 37 | 10 | +66.5% | 28 Aug 2026 | |
| Kevin Strang | Buy 100%Hold 0%Sell 0% | 2 | 1 | n/a | Under 5 targets | 21 Aug 2026 |
| Bruno Montanari | Buy 0%Hold 100%Sell 0% | 16 | 6 | +30.8% | 5 Aug 2026 | |
| Robert Cox | Buy 37%Hold 53%Sell 11% | 108 | 23 | +10.7% | 3 Aug 2026 | |
| Mike Harris | Buy 80%Hold 20%Sell 0% | 23 | 8 | +32.6% | 29 Jul 2026 | |
| Alexander Duval | Buy 71%Hold 29%Sell 0% | 59 | 7 | +5.9% | 27 Jul 2026 | |
| Marcio Farid | Buy 50%Hold 50%Sell 0% | 26 | 7 | +26.4% | 27 Jul 2026 | |
| Leah Jordan | Buy 45%Hold 36%Sell 18% | 77 | 21 | +14.9% | 24 Jul 2026 | |
| Carly Davenport | Buy 36%Hold 36%Sell 27% | 77 | 26 | +15.8% | 16 Jul 2026 | |
| David Roman | Buy 52%Hold 45%Sell 3% | 194 | 42 | +14.4% | 15 Jul 2026 | |
| Scott Fidel | Buy 65%Hold 25%Sell 10% | 2 | 1 | n/a | Under 5 targets | 15 Jul 2026 |
| Ryan Nash | Buy 33%Hold 40%Sell 27% | 564 | 59 | +17.8% | 15 Jul 2026 | |
| Tina Hou | Buy 100%Hold 0%Sell 0% | 62 | 12 | +31.2% | 13 Jul 2026 | |
| Manish Adukia | Buy 60%Hold 20%Sell 20% | 44 | 3 | +24% | 27 Jun 2026 | |
| Brett Feldman | Buy 0%Hold 100%Sell 0% | 281 | 42 | +11% | 26 Jun 2026 | |
| Toshiya Hari | n/a | 928 | 63 | +18.4% | 25 Jun 2026 | |
| Matthew Martino | Buy 83%Hold 17%Sell 0% | 8 | 3 | +17.6% | 18 Jun 2026 | |
| James Sheehan | n/a | 84 | 22 | +31% | 17 Jun 2026 | |
| Timothy Zhao | Buy 75%Hold 25%Sell 0% | 44 | 10 | +33.4% | 12 Jun 2026 | |
| Asad Haider | Buy 67%Hold 33%Sell 0% | 53 | 18 | +13.8% | 12 Jun 2026 | |
| Mohammed Moawalla | Buy 100%Hold 0%Sell 0% | 14 | 4 | -18.3% | 10 Jun 2026 | |
| Allen Chang | Buy 100%Hold 0%Sell 0% | 37 | 7 | +34.2% | 10 Jun 2026 | |
| Jamie Perse | n/a | 115 | 20 | +24.5% | 8 Jun 2026 | |
| Adam Hotchkiss | Buy 50%Hold 45%Sell 5% | 185 | 30 | +38.2% | 5 Jun 2026 | |
| Matthew Sykes | Buy 100%Hold 0%Sell 0% | 416 | 68 | +20.7% | 5 Jun 2026 | |
| James Quigley | Buy 50%Hold 50%Sell 0% | 38 | 8 | +11.3% | 3 Jun 2026 | |
| Lisa Yang | n/a | 36 | 10 | -16.4% | 3 Jun 2026 | |
| Chris Shibutani | n/a | 323 | 54 | +49.7% | 2 Jun 2026 | |
| Corinne Jenkins | Buy 45%Hold 45%Sell 9% | 238 | 53 | +43% | 2 Jun 2026 | |
| Christine Cho | Buy 36%Hold 23%Sell 41% | 80 | 15 | +18.1% | 15 May 2026 | |
| Daniela Costa | Buy 50%Hold 50%Sell 0% | 30 | 10 | +66% | 11 May 2026 | |
| Ben Miller | Buy 89%Hold 11%Sell 0% | 45 | 9 | +50.7% | 7 May 2026 | |
| Elsie Cheng | Buy 100%Hold 0%Sell 0% | 10 | 3 | +25.5% | 4 May 2026 | |
| Anthony Valentini | Buy 21%Hold 68%Sell 11% | 25 | 15 | +12.5% | 20 Apr 2026 | |
| Michele Della Vigna | Buy 0%Hold 100%Sell 0% | 16 | 6 | +53.8% | 20 Apr 2026 | |
| Corinne Johnson | Buy 67%Hold 33%Sell 0% | 79 | 17 | +20% | 14 Apr 2026 | |
| Charles Perron-Piche | Buy 100%Hold 0%Sell 0% | 10 | 4 | +21.1% | 13 Apr 2026 | |
| Rajan Sharma | Buy 50%Hold 0%Sell 50% | 24 | 10 | +82.7% | 9 Apr 2026 | |
| Sumeet Jain | Buy 0%Hold 67%Sell 33% | 11 | 2 | +0.6% | 3 Apr 2026 | |
| Lincoln Kong | Buy 75%Hold 25%Sell 0% | 81 | 11 | +25.8% | 26 Mar 2026 | |
| Heath Terry | n/a | 151 | 18 | +19.1% | 18 Mar 2026 | |
| Shuo Yang | Buy 0%Hold 0%Sell 100% | 7 | 3 | -3.1% | 13 Mar 2026 | |
| Carlos Macedo | n/a | 4 | 2 | n/a | Under 5 targets | 2 Mar 2026 |
| Jonathan Keypour | Buy 0%Hold 50%Sell 50% | 22 | 2 | +9.7% | 27 Feb 2026 | |
| Andre Benjamin | n/a | 23 | 8 | +14.3% | 19 Feb 2026 | |
| Nathan Rich | n/a | 187 | 30 | +9.9% | 17 Feb 2026 | |
| Thiago Bortoluci | Buy 67%Hold 0%Sell 33% | 55 | 11 | +7.8% | 11 Feb 2026 | |
| Luca Cipiccia | n/a | 4 | 2 | n/a | Under 5 targets | 11 Feb 2026 |
| Eric Cha | Buy 100%Hold 0%Sell 0% | 17 | 5 | +177.8% | 10 Feb 2026 | |
| Matt Dellatorre | Buy 80%Hold 20%Sell 0% | 15 | 4 | +23.8% | 9 Feb 2026 | |
| Louise Singlehurst | Buy 100%Hold 0%Sell 0% | 46 | 11 | +45.8% | 30 Jan 2026 | |
| Stephen Laws | n/a | 158 | 21 | +24.7% | 28 Jan 2026 |
Analysts with a call in the past 12 months, latest first. Price targets, upside and targets met are each analyst's full Goldman Sachs record, as on AnaChart stock pages, shown from 5 targets. Updated daily.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 13 Nov 2026 | HOOD | James Yaro | Cut | $128 → $115 | Buy |
| 13 Nov 2026 | RSKD | Will Nance | Raised | $5.50 → $9 | Sell |
| 13 Nov 2026 | DTM | John Mackay | Maintained | $127 | Sell |
| 13 Nov 2026 | KLC | George Tong | Raised | $2.90 → $3.40 | Hold |
| 12 Nov 2026 | BV | George Tong | Cut | $11.10 → $8.70 | Sell |
| 12 Nov 2026 | CWK | Julien Blouin | Target set | $19 | Buy |
| 12 Nov 2026 | GO | Kate McShane | Cut | $9 → $8 | Sell |
| 12 Nov 2026 | XP | Tito Labarta | Raised | $23 → $31 | Buy |
| 12 Nov 2026 | ODD | Bonnie Herzog | Raised | $8 → $10 | Sell |
| 12 Nov 2026 | NVDA | James Schneider | Cut | $300 → $220 | Buy |
| 10 Nov 2026 | CG | Alexander Blostein | Cut | $69 → $58 | Buy |
| 10 Nov 2026 | HRB | George Kelly | Raised | $33 → $40 | Sell |
| 10 Nov 2026 | IONS | Salveen Richter | Cut | $56 → $41 | Hold |
| 9 Nov 2026 | FTDR | Eric Sheridan | Raised | $81 → $93 | Hold |
| 9 Nov 2026 | MRNA | Salveen Richter | Raised | $137 → $195 | Hold |
| 6 Nov 2026 | GXO | Patrick Creuset | Raised | $61 → $66 | Buy |
| 6 Nov 2026 | SEDG | Brian Lee | Cut | $29 → $25 | Sell |
| 5 Nov 2026 | CLVT | George Tong | Cut | $2.60 → $2.30 | Hold |
| 5 Nov 2026 | DOCN | Gabriela Borges | Cut | $179 → $156 | Buy |
| 5 Nov 2026 | FIS | Will Nance | Cut | $57 → $35 | Buy |
| 5 Nov 2026 | LUMN | Michael Ng | Cut | $7.25 → $5 | Hold |
| 5 Nov 2026 | MMM | Joe Ritchie | Raised | $92.81 → $225 | Buy |
| 5 Nov 2026 | PCOR | Kash Rangan | Raised | $70 → $90 | Buy |
| 5 Nov 2026 | RARE | Salveen Richter | Cut | $19 → $17 | Hold |
| 5 Nov 2026 | TASK | James Schneider | Raised | $7 → $8 | Sell |
The most recent target from each analyst on each stock. Updated daily.
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
JefferiesMizuhoH.C. WainwrightEvercoreNeedham
Goldman Sachs analysts issued 2,172 ratings from 31 October 2025 to 30 October 2026: 1,088 Buy, 806 Hold and 278 Sell, on 916 stocks.
63.3% of the 13,205 targets its analysts set above the share price from 2008 to October 2025 were reached within 12 months. For those reached, the median wait was 70 days.
By price targets in the past 12 months: Eric Sheridan (148), James Schneider (97), Mark Delaney (92).
Technology leads with 19% of the stocks it rated in the past 12 months.
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.